| Join | Site Map | Contact | Home
General Information Meeting Agenda Abstracts Exhibits Sponsors Registration Hotel & Travel

Transgenic & In Vivo Mutagenesis Special Interest Group

Breakfast Meeting Agenda

Sunday, October 25, 2009

7:00 AM–8:30 AM

 

Breakfast Meeting

 

 

Transgenic & In Vivo Mutagenesis Special Interest Group

Leaders: Kathleen A. Hill, The University of Western Ontario and  Manju Manjanatha, National Center for Toxicological Research, U.S. FDA

 

 

7:00 AM

General Introduction
Nominations and Elections for Chair and Secretary TIVM SIG 2009–2010
Circulate membership list update
New Business

Short Presentations (10 Min talk + 5 min discussion) of topics selected from the EMS abstracts

7:15 AM–7:30 AM

(Poster 53) “Effect of p53 genotype on gene expression profile in murine testis”
by Rohan Kulkarni, USFDA, (870) 543-7429

7:30 AM–7:45 AM

(Poster 47) “Role of altered hepatic microRNA expression in the pathogenesis of nonalcoholic hepatosteatosis in mice induced by methyl-deficiency”
by Athena Starlard-Davenport, USFDA, (870) 543-7906

7:45 AM–8:00 AM

(Poster 37) “Validation of a multi-endpoint assay in rats: Bone marrow micronucleus, comet and flow cytometric peripheral blood micronucleus”
by Damian Bowen, Covance Labs

8:00 AM–8:15 AM

(Poster 73) “Combining the in vivo comet and micronucleus assays: A practical approach to genotoxicity testing and data interpretation”
by Marie Z. Vasquez, Helix3, (919) 462-8105, ext. 108

8:15 AM–8:30 AM

(Poster 30) “Simultaneous measurement of B(a)P-induced pigA and lacZ mutations and micronuclei in Muta Mouse”
by Christine Lemieux, Health Canada, (613) 960-1600

8:30 AM–Adjourn